2 results
Approved WMORecruiting
Primary objective: To explore the safety and feasibility of neoadjuvant capecitabine, oxaliplatin, docetaxel, and atezolizumab in GE-junction and gastric adenocarcinoma Secondary objectives: • To assess pathological tumor regression and rates of…
Approved WMORecruiting
• To assess which preoperative regimen provides superior event free survival 1 year after randomisation in patients with resectable gastric cancer